irrit
exercis
cold
air
combin
factor
asthma
exacerb
involv
either
slow
onset
symptom
rapid
declin
respiratori
statu
persist
acut
allergen
irrit
exposur
promot
inflamm
bronchoconstrict
airway
hyperrespons
ongo
basi
allergen
exposur
trigger
biphas
respons
earli
respons
occur
within
minut
allergen
exposur
result
rhinorrhea
sneez
itch
eye
nose
bronchospasm
secondari
releas
histamin
preform
mediat
inflamm
latephas
respons
peak
hour
allergen
exposur
develop
eosinophil
inflamm
tcell
infiltr
airway
exacerb
asthma
result
allergen
exposur
phase
must
treat
medic
treat
symptom
earli
phase
well
subsequ
inflamm
late
phase
viral
infect
caus
asthma
symptom
promot
eosinophil
neutrophil
airway
inflamm
viralinduc
asthma
exacerb
common
children
fact
major
acut
asthma
admiss
associ
viral
infect
children
adult
risk
exacerb
asthma
modifi
patient
underli
inflammatori
state
level
airway
hyperreact
patient
reduc
airway
inflamm
adequ
control
therapi
less
like
sever
asthma
flare
expos
offend
agent
present
acut
asthma
may
vari
patient
experi
worsen
airflow
obstruct
associ
respiratori
distress
patient
often
complain
short
breath
chest
tight
wheez
patient
describ
chest
pain
cough
fatigu
caregiv
may
report
observ
breathless
troubl
speak
decreas
activ
retract
rapid
breath
wheez
nois
relentless
cough
physic
examin
tachypnea
present
often
accompani
tachycardia
puls
oximetri
may
reveal
decreas
oxygen
satur
evid
increas
respiratori
effort
intercost
supraclavicular
subcost
retract
infant
young
children
may
demonstr
nasal
flare
head
bob
paradox
motion
thoracoabdomin
wall
ie
expans
abdomin
girth
inspir
anoth
use
sign
increas
work
breath
auscult
chest
frequent
reveal
wheez
prolong
expiratori
phase
rale
crackl
often
heard
may
shift
locat
period
minut
hour
migratori
atelectasi
assess
air
movement
determin
loud
breath
sound
variou
area
chest
may
also
vari
time
patient
poor
air
movement
may
minim
wheez
passag
air
airway
gener
wheez
sound
air
exchang
improv
wheez
may
becom
pronounc
convers
patient
deterior
clinic
cours
may
diminish
wheez
indic
worsen
air
movement
perhap
respiratori
insuffici
agit
somnol
worrisom
sign
may
indic
hypoxemia
hypercapnia
impend
respiratori
failur
patient
present
without
signific
wheez
promin
cough
manifest
asthma
often
refer
coughvari
asthma
believ
pathophysiolog
respons
treatment
similar
classic
asthma
mani
condit
result
acut
chronic
respiratori
symptom
mimic
asthma
syndrom
condit
discuss
follow
text
anatom
abnorm
consid
young
children
frequent
episod
cough
wheez
inhal
foreign
bodi
common
toddlerag
children
chapter
problem
may
manifest
cough
stridor
wheez
age
group
gastroesophag
reflux
mimic
contribut
underli
asthma
chapter
cystic
fibrosi
genet
disord
also
present
chronic
cough
recurr
episod
wheez
chapter
viral
infect
often
caus
wheez
childhood
well
respiratori
syncyti
viru
common
caus
infantil
bronchiol
respiratori
virus
rhinoviru
parainfluenza
viru
coronaviru
adenoviru
influenza
virus
also
common
infecti
agent
viral
bronchiol
associ
edema
bronchospasm
increas
mucu
product
smaller
airway
featur
overlap
asthma
chapter
respiratori
viral
infect
known
precipit
asthma
exacerb
may
difficult
determin
whether
wheez
repres
isol
episod
bronchiol
asthma
exacerb
trigger
respiratori
viru
atyp
respiratori
infect
agent
mycoplasma
chlamydia
pneumonia
bordetella
pertussi
parapertussi
present
chronic
cough
cough
associ
infect
persist
sever
month
function
disord
coexist
mimic
asthma
includ
vocal
cord
dysfunct
vcd
psychogen
cough
vcd
usual
present
adolesc
upper
airway
laryng
inspiratori
expiratori
stridor
may
difficult
distinguish
lower
airway
wheez
diagnosi
vcd
confirm
laryngoscopi
demonstr
paradox
adduct
vocal
cord
inspir
psychogen
cough
habitu
cough
also
persist
month
often
occur
acut
respiratori
ill
habitu
cough
characterist
sound
describ
barki
honk
cough
exagger
stress
attent
cough
disappear
sleep
featur
help
distinguish
entiti
coughvari
asthma
key
featur
vcd
psychogen
cough
lack
respons
asthma
therapi
addit
associ
hypoxia
initi
evalu
patient
present
asthma
exacerb
includ
assess
acut
respiratori
symptom
sign
symptom
coexist
precipit
condit
treatment
initi
present
histori
obtain
characterist
patient
asthma
symptom
pattern
frequenc
symptom
precipit
aggrav
factor
well
featur
indic
sever
level
control
asthma
tabl
physic
examin
provid
clue
sever
current
ill
well
presenc
comorbid
condit
import
physic
paramet
includ
respiratori
rate
work
breath
air
entri
wheez
oxygen
satur
work
breath
refer
use
accessori
muscl
respir
involv
nasal
flare
abdomin
retract
depth
respir
exacerb
asthma
physic
find
may
vari
evolv
treatment
progress
acut
condit
quiet
silent
chest
worrisom
sign
often
flare
asthma
mani
time
last
year
mani
time
use
oral
steroid
mani
time
last
year
mani
emerg
room
visit
mani
visit
hospit
ever
intens
care
unit
poor
movement
air
associ
respiratori
insuffici
failur
asymmetri
auscultatori
find
may
indic
condit
unequ
breath
sound
found
pneumonia
pleural
effus
especi
depend
region
lung
atelectasi
unilater
breath
sound
may
indic
aspir
foreign
bodi
pneumothorax
side
diminish
breath
sound
may
accompani
hyperreson
side
especi
signific
air
trap
present
chest
radiograph
typic
need
patient
known
asthma
straightforward
asthma
exacerb
typic
radiograph
find
includ
hyperinfl
peribronchi
thicken
atelectasi
fig
chest
radiograph
may
help
concern
pneumonia
pleural
effus
pneumothorax
pneumomediastinum
foreign
bodi
aspir
classif
system
determin
sever
asthma
exacerb
children
year
age
older
provid
tabl
patient
mild
distress
typic
slightli
increas
respiratori
rate
may
use
accessori
muscl
respir
endexpiratori
wheez
good
air
entri
patient
sever
distress
work
hard
breath
inspiratori
expiratori
wheez
often
hypox
sign
impend
respiratori
failur
provid
tabl
infant
children
younger
year
age
clue
breathless
includ
difficulti
reluct
feed
chang
cri
pattern
eg
softer
shorter
chang
vital
sign
younger
patient
must
interpret
context
normal
valu
age
rang
interestingli
paradox
thoracoabdomin
movement
sign
associ
sever
respiratori
distress
older
children
may
seen
young
children
infant
even
state
mild
moder
respiratori
distress
object
measur
evalu
acut
asthma
includ
pulmonari
function
test
puls
oximetri
arteri
blood
gase
patient
exacerb
asthma
risk
hypoxemia
result
patient
requir
frequent
monitor
ensur
adequ
oxygen
continu
puls
oximetri
recommend
sever
exacerb
wherea
intermitt
oximetri
may
accept
clinic
cours
improv
arteri
blood
ga
paramet
typic
obtain
critic
ill
patient
clinic
deterior
sign
respiratori
insuffici
failur
arteri
blood
gase
may
reveal
hypoxemia
ventilationperfus
mismatch
respiratori
alkalosi
hypocapnia
secondari
hyperventil
normal
elev
partial
pressur
carbon
dioxid
paco
may
harbing
respiratori
failur
may
associ
decreas
blood
ph
respiratori
acidosi
pulmonari
function
test
use
assess
lung
function
even
asthma
exacerb
spirometr
indic
forc
expiratori
volum
second
fev
peak
expiratori
flow
rate
pefr
use
assess
sever
asthma
howev
spirometri
often
readili
avail
acut
care
set
pefr
use
instead
handheld
peak
flowmet
measur
pefr
normal
valu
establish
accord
age
gender
height
tabl
pefr
provid
measur
largeairway
flow
measur
rate
airflow
liter
per
minut
flare
asthma
exacerba
tion
worsen
pefr
typic
becom
lower
baselin
may
reflect
sever
exacerb
patient
present
emerg
room
asthma
exacerb
fev
typic
normal
pefr
less
normal
monitor
pefr
also
assist
taper
medic
recoveri
phase
acut
hospit
pefr
effort
techniqu
depend
therefor
reliabl
remain
concern
use
conjunct
paramet
sever
assess
patient
see
chapter
exacerb
asthma
treat
combin
support
therapi
pharmacolog
intervent
treatment
tailor
sever
symptom
adjust
accord
patient
respons
therapi
adequ
hydrat
establish
maintain
either
oral
intraven
fluid
physiolog
monitor
includ
vital
sign
puls
oximetri
oxygen
supplement
provid
maintain
oxygen
satur
safe
rang
rang
wide
debat
agre
level
greater
need
mani
target
level
greater
class
medic
work
stimul
receptor
caus
activ
adenyl
cyclas
increas
product
cyclic
monophosph
camp
increas
camp
depend
site
stimul
result
relax
bronchial
smooth
muscl
stimul
skelet
cardiac
muscl
inhibit
releas
inflammatori
mediat
stabil
mast
cell
membran
albuterol
one
shortact
adrenerg
agent
use
firstlin
therapi
acut
asthma
exacerb
abil
rapidli
open
airway
albuterol
administ
nebul
either
continu
intermitt
metereddos
inhal
mdi
spacer
devic
studi
compar
amount
medic
deliv
lung
given
mdi
spacer
versu
nebul
two
mode
consid
equival
patient
use
proper
techniqu
mdispac
method
deliveri
dose
inform
provid
tabl
paradox
transient
worsen
hypoxia
increas
ventilationperfus
mismatch
seen
administr
albuterol
medic
caus
increas
cardiac
output
lead
increas
perfus
unventil
lung
side
effect
includ
sinu
tachycardia
tremor
palpit
headach
agit
ventricular
irrit
eg
ventricular
prematur
contract
ventricular
tachycardia
addit
frequent
continu
dose
adrenerg
agent
lead
hypokalemia
patient
receiv
treatment
serum
potassium
level
check
period
nonselect
adrenerg
agent
eg
epinephrin
also
caus
transient
hyperglycemia
elev
neutrophil
count
result
demargin
albuterol
actual
racem
mixtur
ralbuterol
salbuterol
ratio
two
stereoisom
levalbuterol
xopenex
made
risom
thought
activ
compon
racem
product
howev
salbuterol
found
bronchoconstrict
activ
select
studi
other
demonstr
activ
eosinophil
vitro
addit
salbuterol
clear
much
less
rapidli
caus
buildup
isom
vivo
oppos
lisom
howev
vast
major
clinic
studi
vitro
pharmacolog
data
shown
signific
differ
cardiopulmonari
side
effect
tremor
compar
racem
risom
albuterol
one
studi
found
decreas
rate
admiss
emerg
depart
use
levalbuterol
versu
racem
albuterol
anoth
studi
show
improv
bronchodil
find
confirm
studi
terbutalin
select
adrenerg
agonist
epinephrin
nonselect
adrenerg
agonist
use
asthmat
respond
albuterol
corticosteroid
deterior
medic
given
subcutan
inject
intraven
infus
bronchodil
seen
within
minut
administr
persist
hour
terbutalin
also
given
via
continu
intraven
infus
start
bolu
titrat
dose
desir
effect
dose
adrenerg
agonist
bronchodil
shown
tabl
corticosteroid
indic
initi
treatment
statu
asthmaticu
potent
antiinflammatori
medic
shown
hasten
recoveri
prevent
recurr
prevent
hospit
mechan
action
effect
corticosteroid
immedi
steroid
bind
intracytoplasm
glucocorticoid
receptor
transloc
nucleu
effect
rna
transcript
posit
neg
fashion
transcript
factor
gener
steroid
lead
downregul
inflammatori
cytokin
corticosteroid
also
activ
histon
deacetylas
inhibit
dna
transcript
chang
transcript
lead
increas
express
adrenerg
receptor
decreas
airway
inflamm
mucu
secret
take
sever
hour
revers
airway
inflamm
benefit
typic
seen
within
hour
administr
corticosteroid
studi
compar
oral
intraven
corticosteroid
found
signific
differ
efficaci
oral
steroid
typic
prefer
intraven
access
requir
suggest
dose
corticosteroid
provid
tabl
anticholinerg
agent
work
competit
inhibit
acetylcholin
muscarin
junction
reliev
cholinergicmedi
bronchoconstrict
nebul
atropin
associ
signific
system
absorpt
anticholinerg
medic
ipratropium
bromid
fewer
side
effect
less
system
absorpt
use
inhal
ipratropium
initi
phase
treatment
shown
effect
reduc
need
hospit
studi
found
benefit
comparison
agonist
alon
wherea
other
shown
slight
advantag
one
three
dose
initi
phase
acut
asthma
exacerb
role
ipratropium
hospit
patient
less
clear
initi
studi
show
clinic
benefit
combin
administr
anticholinerg
medic
increas
bronchodil
although
controversi
effect
persist
nonetheless
mani
institut
use
combin
agonist
anticholinerg
medic
initi
phase
acut
asthma
exacerb
studi
examin
use
anticholinerg
medic
monotherapi
also
controversi
dose
list
tabl
initi
aforement
standard
therapi
improv
level
respiratori
distress
symptom
progress
addit
intervent
may
necessari
clinic
experi
expertis
avail
particular
institut
consid
decis
safe
transfer
facil
abl
provid
critic
care
manag
anticip
arrang
expedit
magnesium
sulfat
studi
bronchodil
sever
asthma
conflict
result
magnesium
thought
inhibit
mast
cell
degranul
increas
bronchial
dilat
decreas
calcium
uptak
bronchial
smooth
muscl
use
consid
patient
fail
improv
worsen
despit
treatment
continu
inhal
agonist
system
corticosteroid
inhal
anticholinerg
agent
intraven
methylxanthin
aminophyllin
commonli
use
past
manag
asthma
exacerb
abil
act
directli
receptor
relax
bronchial
smooth
muscl
concern
regard
toxic
efficaci
class
medic
avail
newer
agent
limit
use
methylxanthin
may
help
prevent
acut
airway
hyperrespons
appear
produc
effect
chronic
howev
lifethreaten
event
cardiac
arrhythmia
seizur
associ
toxic
level
theophyllin
result
methylxanthin
recommend
adjunct
therapi
close
monitor
serum
concentr
cardiac
monitor
studi
examin
use
intraven
methylxanthin
children
adult
sever
asthma
shown
mix
benefit
recent
cochran
review
found
theophyllin
addit
agonist
glucocorticoid
without
anticholinerg
improv
lung
function
within
hour
treatment
howev
appar
reduct
symptom
number
nebul
treatment
length
hospit
stay
aminophyllin
requir
load
dose
follow
continu
infus
reach
maintain
therapeut
level
see
tabl
dose
titrat
accord
serum
level
clinic
efficaci
side
effect
heliox
mixtur
helium
oxygen
use
inhal
agent
thought
improv
airflow
creat
ga
similar
viscos
air
lower
densiti
turn
increas
ventil
decreas
work
breath
heliox
indic
patient
refractori
exacerb
asthma
respiratori
failur
impend
patient
high
oxygen
requir
may
abl
toler
heliox
need
higher
fio
heliumoxygen
mixtur
provid
heliox
also
lower
bodi
temperatur
high
thermal
conduct
mixtur
therefor
patient
need
temperatur
monitor
close
dose
nonstandard
therapi
shown
tabl
advers
effect
medic
list
tabl
initi
therapi
statu
asthmaticu
outlin
nhlbi
guidelin
fig
brief
patient
first
treat
inhal
adrenerg
agonist
eg
inhal
albuterol
corticosteroid
either
oral
intraven
need
oxygen
inhal
anticholinerg
ipratropium
bromid
may
ad
patient
demonstr
prompt
improv
patient
signific
improv
initi
intervent
may
requir
hospit
hospit
recommend
patient
continu
moder
sever
sever
symptom
initi
intervent
treatment
inhal
albuterol
either
everi
hour
nebul
mdi
spacer
deliv
continu
nebul
corticosteroid
therapi
oral
toler
intraven
continu
continu
inhal
anticholinerg
agent
may
consid
although
benefit
remain
unproven
patient
continu
deterior
must
monitor
respiratori
insuffici
failur
arteri
blood
ga
measur
use
confirm
condit
reveal
decreas
ph
elev
partial
pressur
carbon
dioxid
paco
increas
alveolararteri
oxygen
gradient
puls
oximetri
remain
poor
monitor
devic
earli
detect
respiratori
failur
oxygen
satur
initi
maintain
despit
signific
degre
hypoventil
addit
supplement
oxygen
would
obscur
evid
respiratori
failur
devic
chapter
patient
impend
respiratori
failur
often
need
mechan
ventilatori
support
patient
stabil
demonstr
improv
therapi
gradual
reduc
withdrawn
ongo
assess
clinic
paramet
perform
includ
respiratori
rate
work
breath
auscultatori
find
requir
supplement
oxygen
patient
remain
comfort
minim
sign
respiratori
distress
dose
inhal
agonist
decreas
patient
receiv
continu
inhal
therapi
dose
may
reduc
subsequ
transit
intermitt
treatment
usual
everi
hour
patient
continu
improv
interv
treatment
extend
similarli
amount
supplement
oxygen
titrat
maintain
oxygen
satur
desir
level
eventu
discontinu
system
corticosteroid
continu
throughout
exacerb
maintain
sever
day
discharg
hospit
inhal
anticholinerg
agent
institut
usual
discontinu
albuterol
begin
taper
mani
hospit
use
clinic
pathway
tool
detail
sequenc
assess
treatment
patient
variou
condit
studi
shown
asthma
clinic
pathway
shorten
hospit
decreas
need
readmiss
week
discharg
asthma
clinic
pathway
allow
multipl
caregiv
includ
nurs
respiratori
therapist
doctor
modifi
treatment
base
structur
assess
nhlbi
guidelin
see
fig
outlin
specif
criteria
use
determin
patient
sever
frequenc
therapi
also
provid
criteria
assist
wean
treatment
pefr
measur
may
use
determin
readi
reduct
medic
pefr
least
baselin
bronchodil
treatment
see
tabl
appropri
space
frequenc
adrenerg
agonist
treatment
techniqu
effort
affect
measur
pefr
therefor
use
conjunct
clinic
indic
improv
patient
sent
home
regimen
oral
corticosteroid
durat
depend
length
sever
ill
patient
frequenc
exacerb
gener
isol
exacerb
treat
oral
corticosteroid
day
howev
patient
admit
hospit
extend
period
prolong
cours
corticosteroid
requir
follow
taper
dose
taper
prescrib
prevent
relaps
symptom
well
prevent
addisonian
crisi
adren
suppress
risk
addisonian
crisi
hypothet
demonstr
studi
addit
patient
receiv
second
cours
steroid
month
undergo
prolong
taper
well
typic
taper
involv
keep
patient
full
daili
dose
corticosteroid
stabl
clinic
statu
achiev
decreas
dose
daili
patient
requir
admiss
hospit
may
adequ
treatment
plan
thu
hospit
offer
opportun
assess
overal
treatment
regimen
patient
evalu
accord
nhlbi
guidelin
shown
tabl
outpati
referr
asthma
specialist
eg
pulmonologist
allergist
associ
reduc
rate
emerg
depart
visit
lifethreaten
asthma
requir
admiss
intens
care
stepdown
unit
sever
persist
asthma
patient
requir
prolong
cours
steroid
multipl
cours
corticosteroid
year
meet
goal
asthma
therapi
respond
treatment
addit
test
perform
necessari
asthma
specialist
may
avail
assist
manag
acut
asthma
exacerb
need
involv
specialist
hospit
may
assist
transit
discharg
critic
care
physician
contact
patient
may
need
manag
intens
care
set
admiss
hospit
individu
base
mani
factor
hospit
consid
patient
follow
patient
readi
go
home
success
wean
albuterol
treatment
everi
hour
receiv
treatment
abl
breath
comfort
ambul
speak
wheez
may
persist
examin
audibl
without
stethoscop
plan
care
includ
ongo
manag
current
acut
exacerb
transit
mainten
therapi
addit
patient
leav
plan
action
manag
subsequ
asthma
exacerb
effort
coordin
primari
care
clinician
involv
asthma
specialist
discharg
import
consid
environ
patient
return
prevent
manag
plan
review
famili
includ
identif
potenti
comorbid
condit
trigger
present
environ
tabl
highlight
discharg
checklist
creat
nhlbi
panel
educ
famili
pathogenesi
asthma
trigger
medic
crucial
prevent
exacerb
admiss
hospit
patient
requir
frequent
admiss
need
treatment
plan
reassess
evalu
comorbid
condit
assess
adher
therapi
review
relev
drug
deliveri
system
import
well
children
experienc
symptom
daili
basi
certain
control
environment
factor
exposur
allergen
assess
infect
note
stepwis
approach
intend
assist
replac
clinic
decisionmak
requir
meet
individu
patient
need
classifi
sever
assign
patient
sever
step
featur
occur
studi
asthma
therapi
infant
gain
control
quickli
possibl
cours
short
system
corticosteroid
may
requir
step
least
medic
necessari
maintain
control
minim
use
shortact
inhal
beta
agonist
overreli
shortact
inhal
beta
agonist
eg
use
approxim
one
canist
month
even
use
everi
day
indic
inadequ
control
asthma
need
initi
intensifi
longtermcontrol
therapi
provid
parent
educ
asthma
manag
control
environment
factor
make
asthma
wors
eg
allergi
irrit
consult
asthma
specialist
recommend
patient
moder
sever
persist
asthma
consid
consult
patient
mild
persist
asthma
step
step
step
step
step
step
minim
chronic
symptom
day
night
review
treatment
everi
month
gradual
stepwis
reduct
treatment
may
possibl
control
maintain
consid
step
first
review
patient
medic
techniqu
adher
environment
control
bronchodil
need
symptom
intens
treatment
depend
upon
sever
exacerb
prefer
treatment
shortact
inhal
beta
agonist
nebul
face
mask
spacehold
chamber
altern
treatment
oral
beta
agonist
viral
respiratori
infect
bronchodil
q
hour
hour
longer
physician
consult
gener
repeat
everi
week
consid
system
corticosteroid
exacerb
sever
patient
histori
previou
sever
exacerb
use
shortact
beta
agonist
time
week
intermitt
asthma
daili
increas
use
persist
asthma
may
indic
need
initi
increas
longtermcontrol
therapi
moder
persist
prefer
treatment
prefer
treatment
altern
treatment
prefer
treatment
altern
treatment
list
alphabet
cromolyn
nebul
prefer
mdi
hold
chamber
leukotrien
receptor
antagonist
daili
medic
need
lowdos
inhal
corticosteroid
nebul
mdi
hold
chamber
without
face
mask
dpi
mediumdos
inhal
corticosteroid
either
leukotrien
receptor
antagonist
theophyllin
mediumdos
inhal
corticosteroid
longact
beta
agonist
mediumdos
inhal
corticosteroid
prefer
treatment
lowtomedium
dose
inhal
corticosteroid
longact
inhal
beta
agonist
altern
treatment
list
alphabet
increas
inhal
corticosteroid
within
mediumdos
rang
lowtomedium
dose
inhal
corticosteroid
either
leukotrien
modifi
theophyllin
need
particularli
patient
recur
sever
exacerb
prefer
treatment
increas
inhal
corticosteroid
within
mediumdos
rang
add
longact
inhal
beta
agonist
altern
treatment
list
alphabet
increas
inhal
corticosteroid
within
mediumdos
rang
add
either
leukotrien
modifi
theophyllin
step
lowdos
inhal
corticosteroid
altern
treatment
list
alphabet
cromolyn
leukotrien
modifi
nedocromil
sustainedreleas
theophyllin
serum
concentr
mcgml
step
daili
medic
need
sever
exacerb
may
occur
separ
long
period
normal
lung
function
symptom
cours
system
corticosteroid
recommend
shortact
bronchodil
puff
shortact
inhal
beta
agonist
need
symptom
intens
treatment
depend
sever
exacerb
treatment
interv
singl
nebul
treatment
need
cours
system
corticosteroid
may
need
use
shortact
beta
agonist
time
week
intermitt
asthma
daili
increas
use
persist
asthma
may
indic
need
initi
increas
longtermcontrol
therapi
step
review
treatment
everi
month
gradual
stepwis
reduct
treatment
may
possibl
control
maintain
consid
step
first
review
patient
medic
techniqu
adher
environment
control
stepwis
approach
meant
assist
replac
clinic
decis
make
requir
meet
individu
patient
need
classifi
sever
assign
patient
sever
step
featur
occur
pef
person
best
fev
predict
gain
control
quickli
possibl
consid
short
cours
system
corticosteroid
step
least
medic
necessari
maintain
control
minim
use
shortact
inhal
beta
agonist
overreli
shortact
inhal
beta
agonist
eg
use
approxim
one
canist
month
even
use
everi
day
indic
inadequ
control
asthma
need
initi
intensifi
longtermcontrol
therapi
provid
educ
selfmanag
control
environment
factor
make
asthma
wors
eg
allergen
irrit
refer
asthma
specialist
difficulti
control
asthma
step
care
requir
referr
may
consid
step
care
requir
minim
advers
effect
medic
step
step
step
cigarett
smoke
caus
symptom
contribut
asthma
exacerb
addit
factor
includ
gastroesophag
reflux
sinus
other
might
exacerb
asthma
explor
elimin
possibl
tabl
asthma
worsen
asthma
symptom
result
smoke
permit
around
asthmat
home
famili
car
physician
provid
assist
caregiv
quit
smoke
appropri
prevent
medic
base
daili
symptom
frequenc
exacerb
maintain
daili
basi
medic
essenti
prevent
asthma
flare
multipl
studi
shown
strong
neg
correl
hospit
admiss
asthma
use
daili
inhal
corticosteroid
suggest
dose
regimen
establish
nation
worldwid
collabor
primari
physician
allergist
pulmonologist
other
exampl
seen
tabl
peak
flowmet
help
manag
asthma
use
appropri
howev
studi
compar
peak
flow
monitor
symptom
recognit
show
benefit
peak
flowbas
action
plan
base
symptom
alon
peak
flowmet
numer
indic
allow
creation
green
yellow
red
zone
see
tabl
green
repres
good
clear
zone
child
person
best
yellow
zone
person
best
indic
time
famili
cautiou
child
may
risk
asthma
symptom
asthma
reliev
medic
start
contact
physician
consid
red
zone
indic
pefr
less
normal
caus
concern
requir
visit
emerg
room
call
doctor
peak
flow
monitor
typic
help
children
good
recogn
symptom
asthma
current
nhlbi
guidelin
recommend
either
symptombas
peak
flowbas
manag
plan
addit
sourc
support
famili
includ
asthma
allergi
foundat
america
mother
asthmat
asthma
chronic
disord
result
airway
inflamm
smooth
muscl
dysfunct
manifest
recurr
episod
wheez
breathless
chest
tight
exacerb
trigger
varieti
stimuli
includ
respiratori
infect
exposur
allergen
irrit
exercis
cold
air
treatment
flare
must
direct
decreas
airway
inflamm
reliev
bronchospasm
provid
support
care
mainstay
pharmacolog
therapi
includ
inhal
shortact
adrenerg
agonist
therapi
system
corticosteroid
support
care
includ
supplement
oxygen
need
mainten
hydrat
mani
pharmacolog
agent
signific
side
effect
therefor
appropri
monitor
requir
patient
sever
symptom
moder
sever
symptom
fail
improv
initi
therapi
candid
admiss
intens
care
set
time
discharg
patient
clear
plan
ongo
treatment
acut
exacerb
transit
mainten
therapi
addit
action
plan
subsequ
exacerb
place
asthma
chronic
inflammatori
diseas
affect
mani
american
research
activ
investig
new
drug
therapi
improv
qualiti
life
asthmat
drug
modifi
immun
respons
current
activ
investig
exampl
one
drug
omalizumab
recombin
human
antiig
antibodi
drug
bind
circul
free
ige
consequ
reduc
level
free
ige
bloodstream
prevent
bind
mast
cell
membran
receptor
thu
curtail
earli
late
asthmat
respons
omalizumab
found
reduc
symptom
exacerb
use
corticosteroid
